Researchers have identified a rare type of cancer cell that cannot make cholesterol, a key nutrient. By targeting this deficiency, scientists may be able to develop new strategies for treating the disease.
Scientists have learned new tricks that could be useful in preventing mosquito-borne illnesses such as Zika and yellow fever. A new study shows that some appetite-reducing drugs can curtail the insects’ impulse to feed on warm-blooded hosts.
Increasingly, bacteria do not succumb to antibiotics. Rockefeller researchers have developed a new class of antimicrobial drug, lysin, with one compound showing promising results in a clinical trial—suggesting that an alternative to antibiotics may be on the horizon.
More than 350 high school students from across the tri-state area attended this year’s event where Kronauer shared how ants can help answer questions about the principles that govern life.
Medical science is holding its breath. For decades, the most it could do for people with HIV was to prevent them from dying of AIDS. Now, new therapies are raising hopes for something more: a world in which the virus will no longer cause suffering or fear.
Bacteria use a multifaceted immune response to get rid of invading DNA. In a new study, researchers identify an enzyme that can destroy foreign genetic material capable of evading a microbe’s first line of defense.
Over 230 attendees from across the country came to campus to learn about a range of topics, such as the federal budget, international science diplomacy, science advocacy, science communication, and careers in science policy.
DNA’s two strands must be separated before its code can be read, or transcribed. By studying the structure of the enzyme RNA polymerase, researchers have elucidated how DNA unwinds and becomes legible.
